CLBFX
Price
$37.04
Change
+$0.12 (+0.33%)
Updated
Aug 8 closing price
Net Assets
253.84B
JABNX
Price
$49.65
Change
+$0.20 (+0.40%)
Updated
Aug 8 closing price
Net Assets
27.35B
Interact to see
Advertisement

CLBFX vs JABNX

Header iconCLBFX vs JABNX Comparison
Open Charts CLBFX vs JABNXBanner chart's image
American Funds American Balanced 529F
Price$37.04
Change+$0.12 (+0.33%)
VolumeN/A
Net Assets253.84B
Janus Henderson Balanced N
Price$49.65
Change+$0.20 (+0.40%)
VolumeN/A
Net Assets27.35B
CLBFX vs JABNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CLBFX vs. JABNX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Buy and JABNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 254B vs. JABNX (27.4B). CLBFX (1.97) and JABNX (1.90) have matching dividends . CLBFX was incepted earlier than JABNX: CLBFX (23 years) vs JABNX (13 years). CLBFX (0.67) is less costly to investors than JABNX (0.57). JABNX is a more actively managed with annual turnover of: 76.00 vs. CLBFX (44.00). CLBFX has a lower initial minimum investment than JABNX: CLBFX (250) vs JABNX (1000000). JABNX annual gain was more profitable for investors over the last year : 11.47 vs. CLBFX (10.27). JABNX (40.38) and CLBFX (39.97) have equivalent 5 years return.
CLBFXJABNXCLBFX / JABNX
Total Expense Ratio0.670.57118%
Annual Report Gross Expense Ratio0.670.57118%
Fund Existence23 years13 years-
Gain YTD9.0239.72893%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets254B27.4B927%
Annual Yield % from dividends1.971.90104%
Returns for 1 year10.2711.4790%
Returns for 3 years33.4132.03104%
Returns for 5 years39.9740.3899%
Returns for 10 years80.9593.7686%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE1.700.05
+3.03%
Aprea Therapeutics
PKG196.431.57
+0.81%
Packaging Corp
ZBIO14.80N/A
N/A
Zenas Biopharma Inc.
TROX3.14-0.09
-2.79%
Tronox Limited
SGMO0.46-0.03
-5.33%
Sangamo Therapeutics